MARKET

SBHMY

SBHMY

Sino Biopharmaceutical Ltd
OTCPK
14.50
NaN%
Opening 09:30 10/07 EDT
OPEN
--
PREV CLOSE
14.50
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
17.21
52 WEEK LOW
10.99
MARKET CAP
13.55B
P/E (TTM)
37.20
1D
5D
1M
3M
1Y
5Y
1D
Chinese biopharma stocks rally as U.S. signals openness to drug licensing
Seeking Alpha · 09/21 09:37
Sino Biopharma receives Chinese rights to two GSK respiratory drugs
Seeking Alpha · 07/08 14:26
AstraZeneca to pay $200M upfront for Sino Biopharmaceutical’s COPD drug license deal
Seeking Alpha · 07/08 04:38
Sanofi bets up to $1.53B to license blood cancer drug from Sino Biopharma unit
Seeking Alpha · 03/04 11:57
About SBHMY
Sino Biopharmaceutical Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Modernised Chinese Medicines and Chemical Medicines segment is mainly engaged in the manufacture, sale and distribution of modernised Chinese medicine products and western medicine products. The Investment segment is mainly engaged in the long term investments business. The Others segment is mainly engaged in the related healthcare and hospital business.

Webull offers Sino Biopharmaceutical Ltd stock information, including OTCPK: SBHMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SBHMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SBHMY stock methods without spending real money on the virtual paper trading platform.